| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
BCRP-IN-1 manufacturers
- (S)-ML753286
-
- $523.00
-
2026-05-11
- CAS:1699720-85-8
- Purity:
- Supply Ability: 10g
- (S)-ML753286
-
- $523.00
-
2025-10-28
- CAS:1699720-85-8
- Purity:
- Supply Ability: 10g
|
| | BCRP-IN-1 Basic information |
| Product Name: | BCRP-IN-1 | | Synonyms: | BCRP-IN-1;(S)-ML753286;Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 2,3,6,7,12,12a-hexahydro-9-methoxy-3-methyl-6-(2-methylpropyl)-, (3S,6S,12aS)-;(S) ML753286,(S)-ML-753286,(S)ML753286 | | CAS: | 1699720-85-8 | | MF: | C20H25N3O3 | | MW: | 355.43 | | EINECS: | | | Product Categories: | | | Mol File: | 1699720-85-8.mol |  |
| | BCRP-IN-1 Chemical Properties |
| Boiling point | 638.0±55.0 °C(Predicted) | | density | 1.27±0.1 g/cm3(Predicted) | | pka | 13.65±0.60(Predicted) | | form | Solid | | color | White to light yellow |
| | BCRP-IN-1 Usage And Synthesis |
| Uses | (S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor with an IC50 of 0.6 μM on BCRP efflux transporter. | | in vivo | (S)-ML753286 (Compound A) shows the potency and a potent pharmacokinetic (PK) profile in rats (lower clearance [1.54 L/h/kg] and higher bioavailability [123%]). XL388 has moderate terminal elimination half-life with t1/2s of 0.9 h and 2.0 h for 2 mg/kg (iv) and 20 mg/kg (po) in rats, respectively[1]. | | References | [1] Li Y, et al. Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles. Bioorg Med Chem Lett. 2016 Jan 15;26(2):551-555. DOI:10.1016/j.bmcl.2015.11.077 |
| | BCRP-IN-1 Preparation Products And Raw materials |
|